CSIMarket
 
Allogene Therapeutics Inc   (NASDAQ: ALLO)
 

Allogene Therapeutics Inc's Suppliers Performance

ALLO's Supply Chain




 
ALLO Costs vs Sales of Suppliers Growth

More on ALLO Suppliers






Allogene Therapeutics Inc's Comment on Supply Chain


The company sources raw materials, including viral vectors, from qualified suppliers for the manufacturing of its product candidates. CF1 is currently used for clinical manufacturing, with potential ongoing reliance on contract development and manufacturing organizations (CDMOs) and other third parties. The company maintains a supply chain with redundant sources, utilizing both internal and external infrastructure to meet clinical trial demands. Strategic agreements related to development, manufacturing, and commercialization exist with Overland Therapeutics Inc. (formerly Allogene Overland Biopharm (CY) Limited), Overland Pharmaceuticals (CY) Inc., HH BioPharma Holdings Ltd., Pfizer, Cellectis, Notch Therapeutics Inc., and Foresight Diagnostics.

Allogene Therapeutics Inc's Comment on Supply Chain


The company sources raw materials, including viral vectors, from qualified suppliers for the manufacturing of its product candidates. CF1 is currently used for clinical manufacturing, with potential ongoing reliance on contract development and manufacturing organizations (CDMOs) and other third parties. The company maintains a supply chain with redundant sources, utilizing both internal and external infrastructure to meet clinical trial demands. Strategic agreements related to development, manufacturing, and commercialization exist with Overland Therapeutics Inc. (formerly Allogene Overland Biopharm (CY) Limited), Overland Pharmaceuticals (CY) Inc., HH BioPharma Holdings Ltd., Pfizer, Cellectis, Notch Therapeutics Inc., and Foresight Diagnostics.







ALLO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Allogene Therapeutics Inc 549.31 0.25 -165.49 152
SUBTOTAL 0.00 0.00 0.00 -


Sources: Allogene Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Allogene Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.